Homepage

scientist working
Bakar Labs
Addition Therapeutics logo

UC Berkeley startup bets on jumping genes for GLP-1 gene therapy

Addition Therapeutics is working on a genetic medicine that would turn a patient’s liver cells into little factories to permanently pump out their own weight loss drugs, the startup told Endpoints News in an exclusive interview. Read post

A symposium to propel ovarian health research beyond the “Dark Ages”

Inspired by breakthroughs in ovarian research, QB3 convened the “Systemic Health Regulated by the Ovarian Pacemaker” symposium on Tuesday, April 14. Scores of researchers, clinicians, biomedical entrepreneurs, and investors converged at Bakar Bio Labs to hear from leaders in ovarian research and learn about the commercialization of, and investment in, new ovarian health technologies. Read post
Bakar Labs in numbers
Powered by QB3

Built for startups. For more than 20 years, QB3 has been the University of California’s center for innovation and entrepreneurship in life science. Through pitch summits, seminars, symposia, podcasts, office hours, internships, and workshops QB3 educates, connects, and elevates the entrepreneurial ecosystem.

Learn about QB3
Decorative graphic of QB3 structure